These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 31539297

  • 1. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
    Chévez-Barrios P, Eagle RC, Krailo M, Piao J, Albert DM, Gao Y, Vemuganti G, Ali MJ, Khetan V, Honavar SG, O'Brien J, Leahey AM, Matthay K, Meadows A, Chintagumpala M.
    J Clin Oncol; 2019 Nov 01; 37(31):2883-2891. PubMed ID: 31539297
    [Abstract] [Full Text] [Related]

  • 2. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
    Luna-Fineman S, Chantada G, Alejos A, Amador G, Barnoya M, Castellanos ME, Fu L, Fuentes-Alabi S, Girón V, Goenz MA, Maldonado C, Méndez G, Morales RA, Ortiz R, Sanchez G, Wilson M, Rodríguez-Galindo C.
    J Clin Oncol; 2019 Nov 01; 37(31):2875-2882. PubMed ID: 31536438
    [Abstract] [Full Text] [Related]

  • 3. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A.
    Arch Ophthalmol; 2011 Nov 01; 129(11):1422-7. PubMed ID: 22084213
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM.
    Arch Ophthalmol; 2001 Jan 01; 119(1):41-8. PubMed ID: 11146725
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW.
    Br J Ophthalmol; 2015 Oct 01; 99(10):1366-71. PubMed ID: 25873648
    [Abstract] [Full Text] [Related]

  • 7. Results of a prospective study for the treatment of unilateral retinoblastoma.
    Chantada GL, Fandiño AC, Guitter MR, Raslawski EC, Dominguez JL, Manzitti J, de Dávila MT, Zubizarreta P, Scopinaro M.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):60-6. PubMed ID: 20486172
    [Abstract] [Full Text] [Related]

  • 8. Outcome of children with retinoblastoma and isolated choroidal invasion.
    Bosaleh A, Sampor C, Solernou V, Fandiño A, Domínguez J, de Dávila MT, Chantada GL.
    Arch Ophthalmol; 2012 Jun 15; 130(6):724-9. PubMed ID: 22801832
    [Abstract] [Full Text] [Related]

  • 9. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW.
    Pediatr Blood Cancer; 2017 Apr 15; 64(4):. PubMed ID: 28221729
    [Abstract] [Full Text] [Related]

  • 10. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.
    Cancer; 2004 Feb 15; 100(4):834-42. PubMed ID: 14770442
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
    Pérez V, Sampor C, Rey G, Parareda-Salles A, Kopp K, Dabezies AP, Dufort G, Zelter M, López JP, Urbieta M, Alcalde-Ruiz E, Catala-Mora J, Suñol M, Ossandon D, Fandiño AC, Croxatto JO, de Dávila MTG, Reaman G, Ravindranath Y, Chantada GL.
    JAMA Ophthalmol; 2018 Jul 01; 136(7):747-752. PubMed ID: 29799944
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH.
    Br J Ophthalmol; 2015 Jul 01; 99(7):949-53. PubMed ID: 25583279
    [Abstract] [Full Text] [Related]

  • 13. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
    Kaliki S, Shields CL, Rojanaporn D, Al-Dahmash S, McLaughlin JP, Shields JA, Eagle RC.
    Ophthalmology; 2013 May 01; 120(5):997-1003. PubMed ID: 23399379
    [Abstract] [Full Text] [Related]

  • 14. Defining High-risk Retinoblastoma: A Multicenter Global Survey.
    Kaliki S, Shields CL, Cassoux N, Munier FL, Chantada G, Grossniklaus HE, Yoshikawa H, Fabian ID, Berry JL, McKenzie JD, Kimani K, Reddy MA, Parulekar M, Tanabe M, Furuta M, Grigorovski N, Chevez-Barrios P, Scanlan P, Eagle RC, Rashid R, Coronado RD, Sultana S, Staffieri S, Frenkel S, Suzuki S, Ushakova TL, Ji X.
    JAMA Ophthalmol; 2022 Jan 01; 140(1):30-36. PubMed ID: 34762098
    [Abstract] [Full Text] [Related]

  • 15. Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy.
    Sreelakshmi KV, Chandra A, Krishnakumar S, Natarajan V, Khetan V.
    Invest Ophthalmol Vis Sci; 2017 Sep 01; 58(11):4654-4661. PubMed ID: 28903151
    [Abstract] [Full Text] [Related]

  • 16. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
    Ye H, Du Y, Chen R, Luo X, Mao Y, Ai S, Ma W, Ding Y, Li Q, Yang H.
    Curr Eye Res; 2016 Nov 01; 41(11):1507-1512. PubMed ID: 27158739
    [Abstract] [Full Text] [Related]

  • 17. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, Lévy-Gabriel C, Brisse HJ, Desjardins L, Doz F.
    J Clin Oncol; 2013 Apr 10; 31(11):1458-63. PubMed ID: 23460706
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
    Mustafa MM, Jamshed A, Khafaga Y, Mourad WA, Al-Mesfer S, Kofide A, El-Husseiny G, Gray A.
    J Pediatr Hematol Oncol; 1999 Apr 10; 21(5):364-9. PubMed ID: 10524448
    [Abstract] [Full Text] [Related]

  • 19. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN, Feng ZX, Hazrati LN, Gallie BL, Soliman SE.
    Ophthalmology; 2019 Sep 10; 126(9):1306-1314. PubMed ID: 30986443
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep 10; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.